Check out the final episode in our entrepreneurship series where we speak with Derek Miller. Derek is a serial biotech entrepreneur with experience at mature biotech start-ups, including his role as Chief Business Officer at Celator Pharmaceuticals in which he oversaw its acquisition by Jazz Pharmaceuticals for around $1.5 billion. Derek breaks down what the different exit options are for life science startups and how to best position your venture for valuation.

Science to Suits is produced by the Penn Biotech Group at the University of Pennsylvania, a graduate student organization supporting students in exploring the life science industry (https://pennbiotechgroup.org/). We would love to hear from you about the podcast - connect with us at [email protected].